The pharmaceutical business operates on a fundamental cycle of innovation, patent-protected exclusivity, and eventual commoditization. For executives in business development, […]
1. The Structural Economics of Pharmaceutical Outsourcing Why Vertical Integration Failed The pharmaceutical industry did not arrive at its current
1. Why Most Drug Launches Fail Before They Begin Roughly two-thirds of new drug launches miss their first-year sales forecasts,
The Definitive Pharmaceutical Drug Launch Playbook: Every Critical Mistake, Dissected Read Post »
The Drug Price Competition and Patent Term Restoration Act of 1984 was not, in any conventional sense, a health policy
Every year, the U.S. pharmaceutical market transfers hundreds of billions of dollars in revenue from branded monopolies to generic competitors.
Executive Summary: A Structural Recalibration of Global Power The global pharmaceutical sector is currently witnessing a definitive structural recalibration. The
The Influence of Emerging Markets on the Pharmaceutical Industry Read Post »
I. Executive Summary Drug repurposing — identifying new clinical indications for approved or investigational compounds — has moved from a
The US pharmaceutical market runs on a single, brutal equation: time equals money, and money equals survival. A company that
Welcome to the most volatile, high-stakes, and strategically critical discipline in modern business: the valuation of pharmaceutical and biotechnology companies.
Valuation of Pharmaceutical Companies: A Comprehensive Analysis of Key Considerations Read Post »
Sign in or create a free account to read this DrugPatentWatch article
